Advertisement
Advertisement
RARE
Ultragenyx Pharmaceutical Inc.
16.02
USDSponsored
+0.95
+6.30%
Oct 20, 16:00 UTC -4
Closed
After-Market
16.02
0.00
+0.01%
Ultragenyx Pharmaceutical Inc. Financial Snapshot
| Market Cap | 1.58B |
| Beta | 0.35 |
| Earnings Per Share (EPS) | -5.84 |
| Price-to-Book (P/B) Ratio | -- |
| Operating Margin | -81.79% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 1.73% |
| Free Cash Flow | -296.00M |
